Advis CEO discusses the recent elections impact on Medicaid.
Advis Vice President, Dan Avants, discusses the new Part B drug plan and its effect on manufacturer pricing.
Advis CEO discusses the reduced payment for outpatient visits and the CMS allowing greater access to virtual visits. What does it mean for providers?
Advis CEO discusses the potential effects of the recently finalized site-neutral payments.
Advis CEO discusses the potential future of Medicare Advantage plans.
Advis CEO discusses the need to merge data from various sources to be able to glean insights.
Advis Vice President, Susan Maupin, discussed the potential impacts of eliminating Medicare coverage of long-term care hospitals.
Advis consultant, Tom Clifford, discusses the advantages of participating in a virtual group.
Advis CEO discusses the need for not-for-profit hospitals to look at nontraditional revenue as their key to success.
Advis Consultant, Tom Clifford discusses hardship exceptions in the MIPS Promoting Interoperability category.
Advis CEO discusses the CMS proposal on Medicare provider applications and the effect that may have on erroneous applications.
We discuss the effect that insurers forming their own network for care delivery will have on the patient.
Advis CEO discusses the new Medicare Advantage plans and the types of coverage those plans may entail.
The Advis Group President and CEO, Lyndean Brick named to Crain’s Custom Media Listing of Notable Women in Chicago Healthcare.
Atul Gawande faces ‘tremendous task’ as CEO of health initiative formed by Berkshire, JPMorgan Chase, Amazon
We discuss the challenges that will be faced by recent pick to head the Amazon, Berkshire and JPMorgan healthcare venture, Atul Gawande.
Advis comments on the recent appointment of Atul Gawande to be the CEO of the healthcare venture by Amazon, JPMorgan and Berkshire Hathaway and what he will have to do to be successful.
We discuss the evolution of the hospital and how healthcare doesn’t have to mean inpatient beds.
Lyndean discusses the Amazon, Berkshire Hathaway and JPMorgan Chase entry into healthcare and what companies may follow suit. Click the link above to listen.
Advis President and CEO offers her thoughts on how to protect Medicare through solutions like better end-of-life planning and reimbursement for palliative care.
Advis CEO breaks down the feasibility of Amazon, Chase and Berkshire Hathaway’s entrance into the healthcare market and how they can leverage their size and resources to create a brand new healthcare model.
Rhapsody is a publication that is circulated throughout United’s First and Business Class cabins. Our CEO shared her thoughts on Amazon, JPMorgan Chase and Berkshire Hathaway’s entry into healthcare and the effect it will have on healthcare insurance.
Advis Group CEO shares her thoughts with Forbes on how innovators are faring better these days.
Advis Group CEO on the retail giant’s push into the Medicaid market and if they are poised to take over Walmart.
Advis Group CEO, offers thoughts on Amazon’s push into the healthcare space by offering Medicaid recipients discounted Amazon Prime memberships.
Advis Group CEO, offers her insight on Micro Hospitals as a way to change the cost curve.
Advis Group CEO, offers insight on how the Anthem imaging policy may force hospitals to reduce costs on MRI and CT scans.
Advis Group CEO, offers her thoughts on the recent healthcare entry by Amazon, Berkshire Hathaway and JPMorgan and what effect it could have on payers.
Advis Group CEO, offers insight regarding Amazon’s entry into the healthcare sector and the subsequent impact this entry will have on the insurance companies.
Advis Group CEO, offers insight regarding recent healthcare mergers and how those mergers will effect consumer choice.
Advis Group CEO, offers her thoughts on the widespread “merger mania” as it relates to the pressure to reduce prices.
Advis Group CEO, sits down with HCPro regarding new CMS survey guidance that is zeroing in on the agency’s definition of a micro hospital.
Advis Group CEO, offers insight on recent mega mergers and the subsequent effect in policy making.